GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (HKSE:00950) » Definitions » Dividend Yield %

Lee's Pharmaceutical Holdings (HKSE:00950) Dividend Yield % : 2.31% (As of Apr. 16, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Lee's Pharmaceutical Holdings Dividend Yield %?

As of today (2025-04-16), the Trailing Annual Dividend Yield of Lee's Pharmaceutical Holdings is 2.31%.

Good Sign:

Lee's Pharmaceutical Holdings Ltd stock Dividend Yield % is close to 1-year high.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's Dividend Yield % or its related term are showing as below:

HKSE:00950' s Dividend Yield % Range Over the Past 10 Years
Min: 0.53   Med: 1.63   Max: 4.42
Current: 2.31

During the past 13 years, the highest Dividend Yield of Lee's Pharmaceutical Holdings was 4.42%. The lowest was 0.53%. And the median was 1.63%.

HKSE:00950's Dividend Yield % is ranked better than
57.65% of 510 companies
in the Drug Manufacturers industry
Industry Median: 1.925 vs HKSE:00950: 2.31

Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.09.

During the past 13 years, the highest Dividend Payout Ratio of Lee's Pharmaceutical Holdings was 0.86. The lowest was 0.02. And the median was 0.28.

As of today (2025-04-16), the Forward Dividend Yield % of Lee's Pharmaceutical Holdings is 3.85%.

Lee's Pharmaceutical Holdings's Dividends per Share for the six months ended in Jun. 2024 was HK$0.01.

During the past 12 months, Lee's Pharmaceutical Holdings's average Dividends Per Share Growth Rate was -10.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -34.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -28.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -9.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Lee's Pharmaceutical Holdings was 36.20% per year. The lowest was -34.80% per year. And the median was 12.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Lee's Pharmaceutical Holdings Dividend Yield % Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Dividend Yield % Chart

Lee's Pharmaceutical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.37 1.83 2.52 1.18 2.11

Lee's Pharmaceutical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.52 1.44 1.18 1.49 2.11

Competitive Comparison of Lee's Pharmaceutical Holdings's Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lee's Pharmaceutical Holdings's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's Dividend Yield % falls into.


;
;

Lee's Pharmaceutical Holdings Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Lee's Pharmaceutical Holdings Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.0200002024-09-122024-09-162024-10-03Cash Dividendsemi-annuallyHKD:HKD 1.000000
HKD 0.0100002024-05-282024-05-302024-06-17Cash Dividendsemi-annuallyHKD:HKD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Lee's Pharmaceutical Holdings's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.03/1.30
=2.31 %

Current Share Price is HK$1.30.
Lee's Pharmaceutical Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.03.

Lee's Pharmaceutical Holdings's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.04/1.30
=3.08 %

Current Share Price is HK$1.30.
Lee's Pharmaceutical Holdings's Dividends per Share for the forward twelve months is calculated as HK$0.02 * 2 = HK$0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lee's Pharmaceutical Holdings  (HKSE:00950) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Lee's Pharmaceutical Holdings Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
Executives
Lion River I N.v. 2201 Interest of corporation controlled by you
Li Zhenfu 2201 Interest of corporation controlled by you
Assicurazioni Generali Spa 2201 Interest of corporation controlled by you
Leelalertsuphakun Wanee 2101 Beneficial owner
Huang Zuie-chin 2201 Interest of corporation controlled by you
Lue Shuk Ping Vicky 2202 Interest of your spouse
Li Xiaoyi 2101 Beneficial owner
Lee Siu Fong 2101 Beneficial owner
Ubs Group Ag 2201 Interest of corporation controlled by you
Panacea Venture Healthcare Fund Ii, L.p. 2101 Beneficial owner
Panacea Innovation Limited 2201 Interest of corporation controlled by you
Guang Dong Min Ying Tou Zi Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Apta Finance Sa 2201 Interest of corporation controlled by you
Qualister Sa 2101 Beneficial owner
Paponi Claudia 2202 Interest of your spouse

Lee's Pharmaceutical Holdings Headlines

No Headlines